Abnormal Liver Function Tests

oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

Interpreting abnormal liver function tests (LFTs) and trying to diagnose any underlying liver disease is a common scenario in Primary Care. Abnormal LFTs may be asymptomatic, and are often inadequately investigated - which may miss an early opportunity of identifying and treating chronic liver disease.[1]

The primary problem may be the liver, or the abnormal results can be secondary to other problems elsewhere in the body.[2]

Alternatively, there may be nothing wrong with the liver at all! Traditionally 'normal' values are defined as being within ± 2 standard deviations meaning that 2.5% of a healthy population will have LFTs outside the normal range. However, as liver disease is frequently asymptomatic, such a 'healthy' population may have significant numbers of people with undiagnosed liver disease, and thus this argument should not be used as an excuse for inadequate investigation.

Liver function tests (LFTs) are readily available and are often included as a baseline investigation for a large number of different presentations. They usually consist of:

  • Bilirubin:
    • Bilirubin is derived from the breakdown of haem in the red blood cells within the reticuloendothelial system.
    • The unconjugated bilirubin then binds albumin and is taken up by the liver.
    • In the liver it is conjugated which then makes it water-soluble and thus allows it to be excreted into the urine.
    • Normally total serum bilirubin is measured; however, the unconjugated and conjugated portions can be determined by measures of the fractions of indirect bilirubin and direct bilirubin respectively.[3]
  • Albumin - sensitive marker of hepatic function, but not useful in the acute stages as it has a long half life (20 days).
  • Total protein.
  • Transferases - usually either alanine aminotransferase (ALT) or aspartate aminotransferase (AST); rarely does a laboratory routinely provide both:
    • These enzymes normally reside inside cells (in cytoplasm) so raised levels usually represent hepatocellular damage. ALT is more specific to the liver, as AST is also found in cardiac and skeletal muscle and red blood cells.
    • Very high levels (>1000 IU/L) suggest drug-induced hepatitis (eg paracetamol), acute viral hepatitis (A or B) , ischaemic, or rarely, autoimmune hepatitis.
    • The ratio of AST to ALT can give some extra clues as to the cause:
      In chronic liver disease ALT >AST, once cirrhosis established AST >ALT. The extremes of the ratio of AST:ALT can also be helpful: >2 suggests alcoholic liver disease, and a ratio of <1.0 suggests nonalcoholic liver disease.[2][4]
  • Gamma-glutamyltransferase (GGT) - also related to the bile ducts. Typically elevated in cholestasis (with elevated ALP) but, if ALP normal, suggests induction of hepatic metabolic enzymes (e.g alcohol or enzyme-inducing drugs).
  • Alkaline phosphatase (ALP) - comes mainly from the cells lining bile ducts but also in bone. Marked elevation is typical of cholestasis (often with elevated GGT) or bone disorders (usually normal GGT). Isoenzyme analysis may help identify source. It is physiologically increased when there is increased bone turnover (eg adolescence) and is elevated in the third trimester of pregnancy (produced by the placenta).

When basic LFTs are abnormal, ensure a full history and examination is performed:

History and examination of a patient with abnormal LFTs

Full history - include: Full examination - look especially for:

Further tests will also be needed to try to find out the underlying cause:

  • The other transaminase - ie ensure you have both ALT and AST results. The ratio of AST to ALT may be useful for distinguishing fatty liver due to alcoholic and nonalcoholic aetiologies (see above).
  • Prothrombin (INR) - sensitive marker of hepatic synthetic function.
  • Viral serology, eg hepatitis B and C, cytomegalovirus (CMV), Epstein-Barr virus and possibly HIV.
  • Autoantibody screen, eg antimitochondrial antibody, anti-smooth muscle antibody and antinuclear antibody.
  • Immunoglobulins (if not available, raised immunoglobulins may be suggested by a raised globulin fraction (total protein minus albumin)).
  • Serum ferritin and transferrin saturation.
  • α-fetoprotein.
  • Copper/ceruloplasmin.
  • α1-antitrypsin.
  • Imaging: ultrasound is noninvasive and helpful to detect structural abnormalities.

Save time & improve your PDP on Patient.co.uk

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »

Consider drug toxicity in all cases[6].
Once results are obtained, determine which of the following scenarios they fit in to:

  • Rise in bilirubin alone: need to know if unconjugated hyperbilirubinaemia or conjugated hyperbilirubinaemia. Usually due to defects of hepatic excretion. It can be detected by measuring the direct bilirubin component of the total bilirubin (>50% confirms the presence of conjugated hyperbilirubinaemia).

    Unconjugated: Conjugated:
  • Obstructive picture or cholestasis: rise in ALP and GGT more than AST and ALT. This may be intrahepatic or extrahepatic (bilirubin will also be raised).
  • Hepatitic picture: rise in AST and ALT more than ALP and GGT:
  • Isolated rise in individual enzymes: for example, ALP and GGT:
    • Isolated rise in GGT:
      • This is most commonly due to alcohol abuse, or enzyme-inducing drugs.
      • An isolated rise can occur even if there is no major liver disease.
      • The rise is not related to the amount of alcohol intake.
      • Also, many heavy alcohol users may have normal GGT.
      • Stopping alcohol for 4 weeks should rectify the abnormality.
    • Isolated rise in ALP:
      • Third trimester of pregnancy (comes from the placenta - a normal finding).
      • If isolated rise in ALP, consider other sources, eg bone or kidney.
        In the elderly consider: ALP is not usually raised in myeloma or osteoporosis (without a fracture).
  • Occasionally, the liver enzymes, eg ALP, GGT, AST or ALT may all be similarly elevated making it difficult to determine whether it is a cholestatic or hepatitic picture.

Any liver abnormalities with evidence of hepatic dysfunction, eg low albumin, raised INR, should be referred to a specialist.[7]

  • If slightly abnormal rise in liver function tests (ie less than twice upper limit of normal):
    • Repeat liver function tests (LFTs) in 6 months' time.
    • If you suspect the cause to be alcohol-related then inform the patient and ask them to abstain, and repeat the tests.
    • Other lifestyle changes may help, eg good diabetes mellitus control and weight loss.
    • If still abnormal, perform further tests, eg viral serology or ultrasonography.
    • If remaining abnormal for longer than six months then consider referral to a specialist.
    • If the patient is unwell despite slightly abnormal LFT's then they may need to be referred more urgently.
  • Very abnormal LFTs (ie more than twice the upper limit of abnormal):
    • Organise further blood tests and imaging.
    • Refer to outpatients - if you suspect the cause may be malignancy then an urgent cancer referral should be made.[7]

Consider urgent referral for hospital admission if a patient is unwell; for example:

  • Severe jaundice
  • Severe ascites
  • Encephalopathy
  • Septic

Otherwise, outpatient referral for anyone less ill if indicated - but try to determine the cause.

Further reading & references

  1. Sherwood P, Lyburn I, Brown S, et al: How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact. BMJ. 2001 Feb 3;322(7281):276-8.
  2. Limdi JK, Hyde GM; Evaluation of abnormal liver function tests. Postgrad Med J. 2003 Jun;79(932):307-12.
  3. Giannini EG, Testa R, Savarino V; Liver enzyme alteration: a guide for clinicians. CMAJ. 2005 Feb 1;172(3):367-79.
  4. Walsh K, Alexander G; Alcoholic liver disease. Postgrad Med J. 2000 May;76(895):280-6.
  5. Giboney PT; Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician. 2005 Mar 15;71(6):1105-10.
  6. Rang HP, Dale MM, Ritter JM and Moore PK. (2003) Pharmacology, 5th ed, Bath, Churchill Livingstone
  7. Heathcote J; Abnormal liver function found after an unplanned consultation: case outcome. BMJ. 2004 Aug 28;329(7464):500; discussion 500-1.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Huw Thomas
Current Version:
Last Checked:
16/07/2010
Document ID:
610 (v23)
© EMIS